Study to Evaluate the Safety of Repatha® in Pregnancy

Mise à jour : Il y a 4 ans
Référence : NCT02906124

Femme Homme

Extrait

To evaluate outcomes of pregnancy in females diagnosed with familial hypercholesterolaemia (FH), exposed to Repatha® during pregnancy. This includes follow-up of their infants to the age of 12 months


Critère d'inclusion

  • Hypercholesterolaemia ,pregnancy


Liens